Has anyone noticed that most of the 52-week low stocks have been therapeutics companies for the past month or so? My first guess was all of the funding cancellations for NIH and CDC but I’m wondering if anyone else has any other ideas as to why so many of them are doing so poorly right now compared to other markets.